Deutsche Bank Ag\ Eiger Bio Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$212 Billion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.89 - $2.52 $5,907 - $16,727	6,638 Added 36.72%	24,714 $22,000
Q4 2022 Feb 13, 2023	BUY	$1.02 - $7.48 $283 - $2,079	278 Added 1.56%	18,076 $21,000
Q3 2022 Nov 14, 2022	SELL	$6.04 - $9.66 $16,531 - $26,439	-2,737 Reduced 13.33%	17,798 $134,000
Q2 2022 Aug 11, 2022	BUY	$4.99 - $8.96 $15,773 - $28,322	3,161 Added 18.19%	20,535 $129,000
Q1 2022 May 13, 2022	SELL	$3.84 - $9.74 $7,902 - $20,044	-2,058 Reduced 10.59%	17,374 $144,000

Q4 2021 Feb 11, 2022	BUY	$5.12 - $8.19 $5,232 - $8,370	1,022 Added 5.55%	19,432 $101,000
Q3 2021 Nov 04, 2021	SELL	$6.68 - $9.1 $3,814 - $5,196	-571 Reduced 3.01%	18,410 $123,000
Q2 2021 Aug 11, 2021	SELL	$7.82 - $9.23 $17,469 - $20,619	-2,234 Reduced 10.53%	18,981 $162,000
Q1 2021 May 13, 2021	SELL	$8.44 - $12.66 $15,740 - $23,610	-1,865 Reduced 8.08%	21,215 $187,000
Q4 2020 Feb 16, 2021	BUY	$7.98 - $12.29 $61,150 - $94,178	7,663 Added 49.7%	23,080 $284,000
Q3 2020 Nov 12, 2020	BUY	$7.96 - $12.42 $30,383 - $47,407	3,817 Added 32.91%	15,417 $125,000
Q2 2020 Aug 13, 2020	SELL	$5.4 - $13.37 $221,848 - $549,279	-41,083 Reduced 77.98%	11,600 $111,000
Q1 2020 May 14, 2020	BUY	$4.91 - $14.7 $195,025 - $583,884	39,720 Added 306.41%	52,683 $358,000
Q4 2019 Feb 14, 2020	BUY	$9.77 - $15.66 $61,619 - $98,767	6,307 Added 94.76%	12,963 $192,000
Q3 2019 Nov 14, 2019	SELL	$9.59 - $12.0 $203,039 - $254,064	-21,172 Reduced 76.08%	6,656 $67,000
Q2 2019 Aug 14, 2019	SELL	$9.54 - $14.96 $16,170 - $25,357	-1,695 Reduced 5.74%	27,828 $293,000
Q1 2019 May 15, 2019	SELL	$10.31 - $14.38 $146,164 - $203,865	-14,177 Reduced 32.44%	29,523 $412,000
Q4 2018 Feb 14, 2019	SELL	$8.63 - $12.4 $93,928 - $134,961	-10,884 Reduced 19.94%	43,700 $443,000
Q3 2018 Nov 14, 2018	SELL	$9.6 - $12.9 $27,513 - $36,971	-2,866 Reduced 4.99%	54,584 $655,000
Q2 2018 Aug 14, 2018	BUY	$8.3 - $16.8 $476,743 - $964,975	57,439 Added 522172.72%	57,450 $700,000
Q1 2018 May 15, 2018	SELL	$8.1 - $16.0 $94,122 - $185,920	-11,620 Reduced 99.91%	11 $0
Q4 2017 Feb 14, 2018	SELL	$10.5 - $14.15 $846,100 - $1.14 Million	-80,581 Reduced 87.39%	11,631 $162,000
Q3 2017 Nov 14, 2017	BUY	$7.7 - $11.55 $710,032 - $1.07 Million	92,212	92,212 $1.01 Million

Others Institutions Holding EIGR

# of Institutions

Shares Held

748K

Call Options Held

Put Options Held

View Full List

About Eiger BioPharmaceuticals, Inc.

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $490M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

More about EIGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account